Catalyst Wire Dossier Catalyst Wire Dossier

ELEPSIA XR 1000 MG

LEVETIRACETAM · TRIPOINT THERAPEUTICS, LLC
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ELEPSIA XR 1000 MG, covering 2018-12-20 to 2024-03-12. Get the full timeline:

Most recent: FDA Approved: ELEPSIA XR 1000 MG — Supplemental Application (TRIPOINT THERAPEUTICS, LLC)

See pricing